Pharmabiz2d
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Lineage begins study of OPC1 delivering device for spinal cord injury treatment
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Business Wire3d
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Le Lézard4d
Neuvotion Receives FDA Clearance for NeuStimtm Providing Non-Invasive, High-Resolution Stimulation for the Hand After Stroke or Spinal Cord Injury
Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products for use in the neurorehabilitation, brain-computer interface (BCI), and physical ...
Lineage Cell Therapeutics initiates study of OPC1 for spinal injury
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
Temple Daily Telegram5d
Spine-zapping implant helps 3 people with muscle-wasting disease walk
Three people with a muscle-destroying disease destined to worsen got a little stronger — able to stand and walk more easily — ...